BridgeBio Pharma (BBIO) Treasury Stock (2020 - 2026)
BridgeBio Pharma's Treasury Shares came in at 11.3 million for Q3 2026, up 48.7% from 7.6 million a year earlier and up 6.7% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Treasury Stock (2020 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma's Treasury Shares was 7.6 million, up 22.7% from FY2024.
- Treasury Shares carries a five-year compound annual growth rate of 25.8% (FY2020 to FY2025).
- Going back by year, Treasury Shares was 6.19 million in FY2024 (unchanged), 6.19 million in FY2023 (unchanged), 6.19 million in FY2022 (unchanged) and 6.19 million in FY2021 (+156.4%).
- The Q3 2026 figure represents the highest quarterly Treasury Shares in data going back to Q1 2020.
- Year-over-year, Treasury Shares has increased for seven consecutive quarters, with growth averaging 24.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Treasury Shares ranged from 0.0% (Q3 2022) to 156.4% (Q4 2021).
- Business Quant data shows BBIO's Treasury Shares at 10.58 million (Q2 2026), 8.68 million (Q1 2026) and 7.6 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Stock (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -3.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 76.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.62 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 64.59 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 115.20 Bn |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | 580.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 580.78 Mn |
| Jun 30, 2026 | 533.28 Mn |
| Mar 31, 2026 | 405.78 Mn |
| Dec 31, 2025 | 323.28 Mn |
| Sep 30, 2025 | 323.28 Mn |
| Jun 30, 2025 | 323.28 Mn |
| Mar 31, 2025 | 323.28 Mn |
| Dec 31, 2024 | 275.00 Mn |
| Sep 30, 2024 | 275.00 Mn |
| Jun 30, 2024 | 275.00 Mn |
| Mar 31, 2024 | 275.00 Mn |
| Dec 31, 2023 | 275.00 Mn |
| Sep 30, 2023 | 275.00 Mn |
| Jun 30, 2023 | 275.00 Mn |
| Mar 31, 2023 | 275.00 Mn |
| Dec 31, 2022 | 275.00 Mn |
| Sep 30, 2022 | 275.00 Mn |
| Jun 30, 2022 | 275.00 Mn |
| Mar 31, 2022 | 275.00 Mn |
| Dec 31, 2021 | 275.00 Mn |
API Access
BridgeBio Pharma Treasury Stock API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();